Ligand Pharmaceuticals LGND Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's free cash flow?
- Ligand Pharmaceuticals (LGND) reported free cash flow of $48.46M in Q1 2026.
- How has Ligand Pharmaceuticals's free cash flow changed year-over-year?
- Ligand Pharmaceuticals's free cash flow increased by 288.9% year-over-year, from -$25.66M to $48.46M.
- What is the long-term trend for Ligand Pharmaceuticals's free cash flow?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's free cash flow has grown at a -8.6% compound annual growth rate (CAGR), from $70.04M to $48.91M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.